ISU Abxis Co., Ltd. (KOSDAQ:086890)
South Korea · Delayed Price · Currency is KRW 4,440.00
-200.00 (-4.31%)
At close: Apr 2, 2026
ISU Abxis Market Cap
ISU Abxis has a market cap or net worth of 180.81 billion as of April 2, 2026. Its market cap has decreased by -13.56% in one year.
Market Cap
180.81B
Enterprise Value
187.35B
Revenue
56.67B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,440.00
Market Cap Chart
Since February 3, 2009, ISU Abxis's market cap has increased from 55.97B to 180.81B, an increase of 223.06%. That is a compound annual growth rate of 7.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 188.95B | -8.15% |
| Dec 30, 2025 | 205.73B | 28.77% |
| Dec 30, 2024 | 159.77B | -23.70% |
| Dec 28, 2023 | 209.40B | 9.75% |
| Dec 29, 2022 | 190.80B | -34.58% |
| Dec 30, 2021 | 291.68B | 43.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kangstem Biotech | 287.81B |
| Bio Solution | 285.48B |
| Genome & Company | 275.31B |
| ABION | 213.09B |
| Ensol Biosciences | 188.71B |
| Prestige Biologics | 187.00B |
| QuadMedicine | 151.56B |
| KoBioLabs | 122.14B |